|
|
||||||||
Journal of the American College of Nutrition, Vol 16, Issue 1 39-45, Copyright © 1997 by American College of Nutrition
JOURNAL ARTICLE |
C. G. Basualdo, E. E. Wein and T. K. Basu
Department of Agricultural, Food and Nutritional Science, University of Alberta, Edmonton, Canada.
OBJECTIVE: Poorly controlled insulin-dependent diabetes mellitus (IDDM) has been reported to be associated with an impaired metabolic availability of vitamin A. The purpose of this study was to examine vitamin A status in a select group with non-insulin dependent diabetes mellitus (NIDDM). METHODS: Participants included 106 (male, female, > 40 years) Plains Cree adults residing in central Alberta, with NIDDM (n = 59) and non-diabetic controls (n = 47). Non-fasting plasma samples were collected and concentrations of retinol, zinc, alpha-tocopherol, total protein, albumin, retinol binding protein (RBP), transthyretin (TTR), cholesterol, triglycerides, glucose, insulin, and fructosamine were determined. Multiple linear regression was used to identify predictors of plasma RBP concentration. Three repeated 24-hour recalls and a food frequency questionnaire were used to determine vitamin A intakes. RESULTS: Diabetic subjects had similar intake and plasma concentration of vitamin A compared to controls. Factors such as alpha-tocopherol, zinc, total protein, albumin, and TTR, which are known to influence vitamin A metabolism, also remained unaffected in subjects with diabetes. Plasma levels of vitamin A carrier protein (RBP), however, were elevated in diabetic subjects, possibly as a result of hyperinsulinemia. The subjects with diabetes had many characteristics of the insulin resistant syndrome, including central obesity, hypertension, and hypertriglyceridemia. Poor metabolic control, based on plasma glucose, was a significant predictor of RBP concentration in diabetic subjects. CONCLUSIONS: The plasma concentration of RBP was elevated in diabetic subjects and was associated with normal circulatory availability of retinol. The subjects with NIDDM, characterized by insulin resistance without insulin deficiency, thus, appear to be associated with normal vitamin A status.
This article has been cited by other articles:
![]() |
J. M. Fernandez-Real, J. M. Moreno, and W. Ricart Circulating Retinol-Binding Protein-4 Concentration Might Reflect Insulin Resistance-Associated Iron Overload Diabetes, July 1, 2008; 57(7): 1918 - 1925. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Reinehr, B. Stoffel-Wagner, and C. L. Roth Retinol-Binding Protein 4 and Its Relation to Insulin Resistance in Obese Children before and after Weight Loss J. Clin. Endocrinol. Metab., June 1, 2008; 93(6): 2287 - 2293. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Yao-Borengasser, V. Varma, A. M. Bodles, N. Rasouli, B. Phanavanh, M.-J. Lee, T. Starks, L. M. Kern, H. J. Spencer III, A. A. Rashidi, et al. Retinol Binding Protein 4 Expression in Humans: Relationship to Insulin Resistance, Inflammation, and Response to Pioglitazone J. Clin. Endocrinol. Metab., July 1, 2007; 92(7): 2590 - 2597. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Vitkova, E. Klimcakova, M. Kovacikova, C. Valle, C. Moro, J. Polak, J. Hanacek, F. Capel, N. Viguerie, B. Richterova, et al. Plasma Levels and Adipose Tissue Messenger Ribonucleic Acid Expression of Retinol-Binding Protein 4 Are Reduced during Calorie Restriction in Obese Subjects but Are Not Related to Diet-Induced Changes in Insulin Sensitivity J. Clin. Endocrinol. Metab., June 1, 2007; 92(6): 2330 - 2335. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Balagopal, T. E. Graham, B. B. Kahn, A. Altomare, V. Funanage, and D. George Reduction of Elevated Serum Retinol Binding Protein in Obese Children by Lifestyle Intervention: Association with Subclinical Inflammation J. Clin. Endocrinol. Metab., May 1, 2007; 92(5): 1971 - 1974. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. V. Silha, B.L. G. Nyomba, W. D. Leslie, and L. J. Murphy Ethnicity, Insulin Resistance, and Inflammatory Adipokines in Women at High and Low Risk for Vascular Disease Diabetes Care, February 1, 2007; 30(2): 286 - 291. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Janke, S. Engeli, M. Boschmann, F. Adams, J. Bohnke, F. C. Luft, A. M. Sharma, and J. Jordan Retinol-binding protein 4 in human obesity. Diabetes, October 1, 2006; 55(10): 2805 - 2810. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. E. Graham, Q. Yang, M. Bluher, A. Hammarstedt, T. P. Ciaraldi, R. R. Henry, C. J. Wason, A. Oberbach, P.-A. Jansson, U. Smith, et al. Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. N. Engl. J. Med., June 15, 2006; 354(24): 2552 - 2563. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Corominola, L. J. Conner, L. S. Beavers, R. A. Gadski, D. Johnson, J. F. Caro, and R. Rafaeloff-Phail Identification of Novel Genes Differentially Expressed in Omental Fat of Obese Subjects and Obese Type 2 Diabetic Patients Diabetes, December 1, 2001; 50(12): 2822 - 2830. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. K. Young, J. Reading, B. Elias, and J. D. O'Neil Type 2 diabetes mellitus in Canada's First Nations: status of an epidemic in progress Can. Med. Assoc. J., September 1, 2000; 163(5): 561 - 566. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |